/

Companies / AbelZeta Pharma

AbelZeta Pharma

People's Republic of China

AbelZeta Pharma is a cell therapy leader focused on discovering, developing and manufacturing therapeutics to address unmet medical needs across hematologic malignancies, inflammatory and immunological diseases and solid tumors.

AbelZeta Pharma, based in People's Republic of China, has 1 investor on file, among them HSG. Its site was last checked 7 Nov 2026: site answers.

Investors

1 investor on file
InvestorEvidenceType
HSGPortfolio pageVenture capital

More from HSG

102 companies on its checked portfolio

Its portfolio leans to AI & Machine Learning (19%), Healthcare & Biotech (15%), Consumer (13%).

See HSG's full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get AbelZeta Pharma and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when HSG adds a company.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/abelzeta.com/investors

# also
GET /v1/companies/abelzeta.com
GET /v1/companies/abelzeta.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing